Skip to main content
. 2020 Mar 11;28(6):312–319. doi: 10.1007/s12471-020-01407-z

Fig. 1.

Fig. 1

Proposed relationship between heart failure with preserved ejection fraction (HFpEF), mitochondrial dysfunction and metabolic syndrome, and the therapeutic potential of trimetazidine. The numbers of the arrows correspond to those in the main text. LV left ventricular